as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹133.34
Change
-0.3 (-0.22%)
Open
₹133.02
Prev. Close
₹133.64
Day High
₹137.8
Day Low
₹133.0
Volume Analysis
Traded
5,753
Delivered
4,786
Delivery %
83.19%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (1)
- •Low return on equity (5.33%)
Opportunities (1)
- •Strong 3-year revenue growth (15.2%)
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹141.22 | ₹139.51 | ₹136.42 | ₹134.71 | ₹131.62 | ₹129.91 | ₹126.82 |
| Fibonacci | ₹139.51 | ₹137.68 | ₹136.54 | ₹134.71 | ₹132.88 | ₹131.74 | ₹129.91 |
| Camarilla | ₹134.66 | ₹134.22 | ₹133.78 | ₹134.71 | ₹132.9 | ₹132.46 | ₹132.02 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-14.68%
1 Week
-5.39%
1 Month
+0.51%
3 Months
-12.9%
6 Months
-22.85%
1 Year
-17.35%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹428.81
Current price is at or below the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
3.58%
Net margin 6.98% × asset turnover 0.3x × equity multiplier 1.71x
Company Overview
Sector
Fast Moving Consumer Goods
Market Cap
₹251 Cr
P/E (TTM)
8.26
ROE
5.33%
Book Value
₹373.0
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 19 Nov 2026. Not investment advice.
TopFund Analysis
Nath Bio-genes (i) Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Fast Moving Consumer Goods sector, at 51/100. The strongest factor is Financial Strength (100/100), while Cash Flow (1/100) is the weakest area to weigh before deciding. Notably: Low return on equity (5.33%). Strong 3-year revenue growth (15.2%).
TopFund Score — Fundamentals Quality
51/100 — AverageData confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Stock is trading at 0.38 times its book value
- +Debtor days have improved from 116 to 87.0 days.
- −Company has a low return on equity of 5.88% over last 3 years.
- −Earnings include an other income of Rs.14.8 Cr.
- −Dividend payout has been low at 9.52% of profits over last 3 years
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Audio recording of 16 Nov 2026 conference call on Q2 and half-year results uploaded.
Presentation on Unaudited Financial Results as of 30th September 2026
Q2 and H1FY27 earnings conference call scheduled for 16 November 2026 at 4:00 PM IST.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 23 | 32 | 43 | 244 | 32 | 37 | 52 | 284 | 44 | 66 | 52 | 328 | 41 |
| Expenses + | 18 | 26 | 39 | 207 | 27 | 29 | 52 | 254 | 38 | 62 | 47 | 293 | 36 |
| Operating Profit | 5 | 6 | 4 | 37 | 5 | 8 | 0 | 29 | 6 | 4 | 4 | 35 | 5 |
| OPM % | 22.11% | 17.8% | 9.13% | 14.98% | 14.94% | 21.81% | 0.81% | 10.32% | 13.93% | 5.41% | 8.68% | 10.7% | 11.36% |
| Other Income + | 0 | 3 | 1 | 0 | 0 | 0 | 4 | 4 | 2 | 4 | 4 | 3 | 4 |
| Interest | 2 | 3 | 1 | 2 | 3 | 4 | 1 | 3 | 4 | 5 | 5 | 4 | 6 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 2 | 5 | 3 | 34 | 1 | 4 | 2 | 29 | 3 | 2 | 2 | 33 | 1 |
| Tax % | 18.92% | 16.78% | 19.14% | 0.74% | -2.78% | 30.08% | 29.86% | 2.28% | 18.88% | 35.22% | 100.4% | 2.18% | 68.7% |
| Net Profit + | 2 | 4 | 3 | 33 | 1 | 3 | 1 | 28 | 3 | 2 | 0 | 32 | 0 |
| EPS in Rs | 1 | 2 | 1 | 18 | 1 | 1 | 1 | 15 | 1 | 1 | 0 | 17 | 0 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| YoY Sales growth | 4 | 25 | -4 | 4 | 43 | 16 | 21 | 16 | 36 | 79 | -1 | 16 | -7 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales + | 97 | 109 | 230 | 234 | 248 | 268 | 358 | 487 |
| Expenses + | 82 | 89 | 193 | 185 | 198 | 217 | 305 | 439 |
| Operating Profit | 15 | 20 | 37 | 49 | 50 | 51 | 53 | 48 |
| OPM % | 15.0% | 18.0% | 16.0% | 21.0% | 20.0% | 19.0% | 15.0% | 10.0% |
| Other Income + | 1 | 1 | -87 | 1 | 4 | 4 | 14 | 15 |
| Interest | 2 | 4 | 11 | 10 | 9 | 11 | 16 | 19 |
| Depreciation | 5 | 5 | 3 | 3 | 3 | 4 | 4 | 4 |
| Profit before tax | 9 | 12 | -63 | 36 | 42 | 41 | 46 | 39 |
| Tax % | -1.0% | 4.0% | 6.0% | 3.0% | 5.0% | 5.0% | 10.0% | — |
| Net Profit + | 9 | 12 | -67 | 35 | 40 | 39 | 42 | 34 |
| EPS in Rs | 6 | 7 | -35 | 18 | 21 | 20 | 22 | 18 |
| Dividend Payout % | 0.0% | 0.0% | -6.0% | 11.0% | 10.0% | 10.0% | 9.0% | — |
| Sales growth | — | 12 | — | 2 | 6 | 8 | 34 | 17 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|
| Reserves | 30 | 41 | 523 | 554 | 591 | 625 | 661 | 690 |
| Borrowings + | 11 | 19 | 93 | 105 | 110 | 123 | 138 | 191 |
| Other Liabilities + | 63 | 82 | 105 | 114 | 160 | 259 | 278 | 312 |
| Total Liabilities | 120 | 158 | 739 | 793 | 880 | 1,026 | 1,097 | 1,213 |
| Fixed Assets + | 21 | 38 | 245 | 244 | 249 | 250 | 249 | 254 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 1 | 0 | 5 | 5 | 6 | 6 | 6 | 6 |
| Other Assets + | 99 | 121 | 490 | 543 | 625 | 770 | 842 | 953 |
| Total Assets | 120 | 158 | 739 | 793 | 880 | 1,026 | 1,097 | 1,213 |
| Equity Capital | 16 | 16 | 19 | 19 | 19 | 19 | 19 | 19 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | — | — | 17 | 38 | 75 | 18 | -13 |
| Cash from Investing Activity + | — | — | -20 | -3 | -27 | -4 | 3 |
| Cash from Financing Activity + | — | — | -22 | -2 | -8 | -2 | -4 |
| Net Cash Flow | — | — | -25 | 34 | 39 | 11 | -13 |
| Free Cash Flow | — | — | 16 | 36 | 48 | 10 | -16 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | — | — | 54 | 80 | 150 | 37 | -22 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 49.72% | 49.76% | 49.8% | 49.83% | 49.83% | 50.24% | 51.73% | 53.31% | 54.08% | 54.17% | 54.13% | 54.21% |
| Promoters | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% |
| FII | 0.32% | 0.27% | 0.21% | 0.18% | 0.19% | 0.21% | 0.41% | 0.32% | 0.31% | 0.22% | 0.26% | 0.18% |
| DII | 4.37% | 4.37% | 4.37% | 4.37% | 4.37% | 3.94% | 2.25% | 0.76% | 0.01% | 0.01% | 0.01% | 0.01% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Fast Moving Consumer Goods — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Nath Bio-genes (i) Ltd (this stock) | 251 | 8.26 | 0.35 | 5.33% |
| The P K Tea Prod Co Ltd | 256 | 305.0 | 1.34 | 0.45% |
| Annapurna Swadisht Ltd | 263 | 6.86 | 0.83 | 9.71% |
| Jayshree Tea & Industries | 234 | — | 0.57 | -7.51% |
| Sayaji Industries Ltd. | 268 | 10.6 | 2.56 | 1.49% |
| Indo-national Limited | 226 | — | 0.75 | -6.95% |
| Sakthi Sugars Ltd | 225 | — | 0.87 | -59.4% |
Which Mutual Funds Hold Nath Bio-genes (i) Ltd?
Frequently Asked Questions about Nath Bio-genes (i) Ltd
Nath Bio-genes (i) Ltd (NATHBIOGEN) closed at ₹133.34 on NSE on 19 November 2026, down 0.3 (0.22%) from the previous close.
Nath Bio-genes (i) Ltd trades on the NSE (National Stock Exchange of India) under the symbol NATHBIOGEN.
Nath Bio-genes (i) Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 8.26.
Nath Bio-genes (i) Ltd has a dividend yield of 1.53%.
Nath Bio-genes (i) Ltd's 52-week high is ₹207.0 and its 52-week low is ₹126.0.
Nath Bio-genes (i) Ltd has a market capitalisation of ₹251 crore.
Nath Bio-genes (i) Ltd has a TopFund Quality Score of 51/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Nath Bio-genes (i) Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.